EXPLEO SOLUTIONS LIMITED vs WIPRO LTD

A side-by-side comparison of EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) and WIPRO LTD (WIPRO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, EXPLEO SOLUTIONS LIMITED leads EXPLEOSOL vs WIPRO on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation40
  • Profitability22
  • Growth11
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

EXPLEOSOL takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

11.18
P/E ratio
14.07
1.63
P/B ratio
2.07
12.59%
Dividend yield
1.13%
₹79.89
EPS
₹12.58

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

19.20%
Return on equity
15.50%
25.00%
Return on capital
18.00%
15.00%
EBITDA margin
19.00%
11.19%
Net margin
14.32%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

7.06%
Revenue CAGR (3Y)
0.78%
-2.55%
Profit CAGR (3Y)
5.29%

Size & financial health

WIPRO takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1,380 Cr
Market cap
₹1.75L Cr
₹1,108 Cr
Revenue
₹92,624 Cr
₹124 Cr
Net profit
₹13,266 Cr
0.01
Debt / equity
0.13
EXPLEO SOLUTIONS LIMITED
  • + ["Company has reduced debt.", "Company is almost debt free."]
WIPRO LTD
  • + ["Stock is providing a good dividend yield of 6.08%.", "Company has been maintaining a healthy dividend payout of 46.7%"]
  • ["The company has delivered a poor sales growth of 8.38% over past five years."]
EXPLEO SOLUTIONS LIMITED full analysis WIPRO LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

EXPLEOSOL vs WIPRO: Share Price, Valuation & Which to Buy | DocStoX